BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations
about
Founder populations and their uses for breast cancer genetics.TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populations.New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencingPeritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers.The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms.Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families.BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
P2860
Q24544179-AA825890-D69A-4C65-B921-A77CE958BAB5Q24812743-BD1355AA-DF3B-4771-81E2-51B4011E16F4Q25255429-17242B6D-A86A-4B19-8493-18C37B0C4BDCQ35600785-D1AAE30A-793C-4C7A-BE33-6087D8AF89A2Q35934073-964FA250-2596-44D9-9A2B-56A990CE1713Q36117690-1004E211-7E86-4294-90F0-65BB58B3EFE3Q36696220-812689A3-8F48-4AB5-817B-A719D71732DBQ37316953-7649F385-EF2A-44C2-83F9-63571127E432Q37364392-861B2FE6-31E7-4D40-B1B6-657E8B2C4F0DQ45870377-422E93DC-2CEB-4305-8CFF-4B25E470BFC5Q50543004-81FE2C92-0389-4A0C-AB84-0D84AEA6367CQ50547545-C9EC81D8-3410-4D08-9A69-FE19F8C9CDC6Q57728295-89D1678F-FF6B-4009-92FA-24AA69A3772F
P2860
BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@ast
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@en
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@nl
type
label
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@ast
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@en
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@nl
altLabel
BRCA1 1675delA and 1135insA Ac ...... t than Less Frequent Mutations
@en
prefLabel
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@ast
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@en
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@nl
P2093
P356
P1433
P1476
BRCA1 1675delA and 1135insA ac ...... t than less frequent mutations
@en
P2093
P356
10.1155/1999/278269
P407
P577
1999-10-01T00:00:00Z